Sex-specific differences in neurological emergencies such as Status epilepticus (SE) remain understudied despite growing recognition of gender disparities in medicine. This study aimes to investigate sex-related differences in etiology, diagnostics, treatment, and outcomes among patients with SE. The investigators conducted a retrospective analysis of 779 patients treated with SE at Marburg University Hospital between 2011 and 2023.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Age at SE Onset
Timeframe: Baseline (day 1)
Diagnosis of SE Subtype
Timeframe: During hospital stay, maximum 30 days
Semiology: Focal vs. Generalized
Timeframe: During hospital stay, maximum 30 days
Non-convulsive SE
Timeframe: During hospital stay, maximum 30 days
History of Epilepsy Prior to SE
Timeframe: Baseline (day 1)
Guideline-based Treatment of SE
Timeframe: During hospital stay, maximum 30 days
Intubation During Treatment of SE
Timeframe: During hospital stay, maximum 30 days
History of Epilepsy Surgery
Timeframe: Baseline (day 1)
Length of Hospital Stay
Timeframe: Up to 100 days
Availability of Brain MRI During Hospital Stay
Timeframe: During hospital stay, maximum 30 days
Time to Brain MRI After SE Onset
Timeframe: During hospital stay, maximum 30 days
EEG with SE Available
Timeframe: During hospital stay, maximum 30 days
EEG Control Available
Timeframe: From hospital stay through follow-up (up to study completion, an average of 1 year)
Functional Outcome at Discharge (mRS)
Timeframe: Through study completion, an average of 12 days
Discharge Destination
Timeframe: Through study completion, an average of 12 days
Survival After One Year
Timeframe: One year after SE onset
Total Costs of Hospital Stay
Timeframe: Through study completion, an average of 12 days
Antiseizure Medication (ASM) Use Prior to SE
Timeframe: Baseline (day 1)
Number of Distinct ASMs Prior to SE
Timeframe: Baseline (day 1)
Type of ASMs Used Prior to SE
Timeframe: Baseline (day 1)
Prehospital Benzodiazepine Use Before SE
Timeframe: Baseline (day 1)
Number of Distinct Prehospital Benzodiazepines
Timeframe: Baseline (day 1)
Type of Prehospital Benzodiazepines Used
Timeframe: Baseline (day 1)
ASM Use During SE Treatment
Timeframe: During hospital stay, maximum 30 days
Number of Distinct ASMs During SE
Timeframe: During hospital stay, maximum 30 days
Type of ASMs Used During SE
Timeframe: During hospital stay, maximum 30 days
In-hospital Benzodiazepine Use
Timeframe: During hospital stay, maximum 30 days
Number of Distinct In-hospital Benzodiazepines
Timeframe: During hospital stay, maximum 30 days
Type of In-hospital Benzodiazepines Used
Timeframe: During hospital stay, maximum 30 days